FDA authorizes Pfizer COVID-19 vaccine boosters for people 65 and older, other at-risk groups
The U.S. Food and Drug Administration authorized Pfizer booster shots Wednesday for seniors and other high-risk Americans, paving the way for third doses to be offered as early as the end of the week. The deliberation follows a recommendation last…